| Literature DB >> 27271590 |
Wenbing Ding1,2, Ye Li3, Guanhua Li4, Hualiang He5, Zhiwen Li6, Youzhi Li7,8.
Abstract
Three new 30-noroleanane triterpenoid saponins, akebonoic acid 28-O-β-d-glucopyranosyl-(1''→6')-β-d-glucopyranosyl ester (1), akebonoic acid 28-O-(6''-O-caffeoyl)-β-d-glucopyranosyl-(1''→6')-β-d-glucopyranosyl ester (Holboelliside A, 2) and 3β,20α,24-trihydroxy-29-norolean-12-en-28-oic acid 3-O-(6'-O-caffeoyl)-β-d-glucopyranoside (Holboelliside B, 3) were isolated from the stems of Holboellia coriacea Diels, together with five known compounds, eupteleasaponin VIII (4), 3α-akebonoic acid (5), quinatic acid (6), 3β-hydroxy-30-norhederagenin (7) and quinatoside A (8). The structures of these compounds were determined on the basis of spectral and chemical evidence. Compounds 1-5 were evaluated for their inhibitory activity against three human tumors HepG2, HCT116 and SGC-7901 cell lines in vitro.Entities:
Keywords: Holboellia coriacea; cytotoxicity; nortriterpenoids; saponins
Mesh:
Substances:
Year: 2016 PMID: 27271590 PMCID: PMC6274467 DOI: 10.3390/molecules21060734
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of compounds 1–8 isolated from H. coriacea, as well as structures of 1a and 3a mentioned in the text.
NMR spectroscopic data for compound 1 in pyridine-d.
| No. | δc | δH (mult., | No. | δc | δH (mult., |
|---|---|---|---|---|---|
| Ag-1 | 38.5 CH2 | 0.98 (m); 1.52 (m) | 23 | 28.2 CH3 | 1.22 (s) |
| 2 | 27.5 CH2 | 1.79–1.82 (m) | 24 | 16.0 CH3 | 1.02 (s) |
| 3 | 77.6 CH | 3.44 (dd, 9.9, 5.6) | 25 | 15.1 CH3 | 0.94 (s) |
| 4 | 38.8 qC | 26 | 17.0 CH3 | 1.12 (s) | |
| 5 | 55.3 CH | 0.84 (d, 11.2) | 27 | 25.5 CH3 | 1.20 (s) |
| 6 | 18.3 CH2 | 1.36 (m); 1.51 (m) | 28 | 175.3 qC | |
| 7 | 32.6 CH2 | 1.35 (m); 1.47 (m) | 29 | 106.7 CH2 | 4.65 (s); 4.71 (s) |
| 8 | 39.4 qC | ||||
| 9 | 47.6 CH | 1.63 (dd, 9.7, 7.4) | Glc-1′ | 95.2 CH | 6.21 (d, 8.0) |
| 10 | 36.8 qC | 2′ | 73.3 CH | 4.12 (m) | |
| 11 | 23.2 CH2 | 1.90 (m) | 3′ | 78.1 CH | 4.19 (m) |
| 12 | 122.9 CH | 5.45 (br s) | 4′ | 70.4 CH | 4.33 (m) |
| 13 | 143.0 qC | 5′ | 77.3 CH | 4.07 (m) | |
| 14 | 41.5 qC | 6′ | 69.0 CH2 | 4.35 (dd, 12.1, 4.9) | |
| 15 | 27.7 CH2 | 1.18 (m); 2.34 (m) | 4.69 (br d, 12.1) | ||
| 16 | 23.0 CH2 | 2.06 (m); 2.14 (m) | Glc-1′′ | 104.8 CH | 5.00 (d, 7.7) |
| 17 | 46.8 qC | 2′′ | 74.6 CH | 4.00 (t, 7.7) | |
| 18 | 47.0 CH | 3.13 (dd, 4.7, 13.4) | 3′′ | 77.8 CH | 4.21 (m) |
| 19 | 41.2 CH2 | 2.20 (m); 2.59 (t, 13.4) | 4′′ | 71.0 CH | 4.19 (m) |
| 20 | 147.9 qC | 5′′ | 77.9 CH | 3.88 (m) | |
| 21 | 29.5 CH2 | 2.09 (m); 2.20 (m) | 6′′ | 62.1 CH2 | 4.48 (br d, 10.5) |
| 22 | 37.1 CH2 | 1.74 (m); 2.03 (m) | 4.32 (m) |
δ in ppm; 1H-NMR: 400 MHz and 13C-NMR 100 MHz.
NMR spectroscopic data for compound 2 in pyridine-d5.
| No. | δc | δH (mult., | No. | δc | δH (mult., |
|---|---|---|---|---|---|
| Ag-1 | 38.4 CH2 | 0.96 (m); 1.51 (m) | 27 | 25.5 CH3 | 1.17 (s) |
| 2 | 27.5 CH2 | 1.79 (m); 1.82 (m) | 28 | 175.2 qC | |
| 3 | 77.6 CH | 3.42 (dd, 11.0, 4.9) | 29 | 106.8 CH2 | 4.63 (s); 4.68 (s) |
| 4 | 38.8 qC | Glc-1′ | 95.2 CH | 6.21 (d, 8.2) | |
| 5 | 55.3 CH | 0.82 (d, 11.9) | 2′ | 73.3 CH | 4.09 (m) |
| 6 | 18.2 CH2 | 1.36 (m); 1.51 (m) | 3′ | 78.1 CH | 4.18 (t, 9.0) |
| 7 | 32.6 CH2 | 1.33 (m); 1.45 (m) | 4′ | 70.4 CH | 4.31 (t, 9.0 ) |
| 8 | 39.4 qC | 5′ | 77.3 CH | 4.05 (m) | |
| 9 | 47.5 CH | 1.60 (dd, 10.9, 6.9) | 6′ | 69.0 CH2 | 4.36 (dd, 11.4, 4.8) |
| 10 | 36.8 qC | 4.73 (br d, 11.4) | |||
| 11 | 23.2 CH2 | 1.86 (m); 1.89 (m) | Glc-1′′ | 104.7 CH | 5.02 (d, 7.6) |
| 12 | 122.9 CH | 5.40 (t, 3.6) | 2′′ | 74.9 CH | 4.02 (m) |
| 13 | 142.9 qC | 3′′ | 78.1 CH | 4.18 (t, 9.0) | |
| 14 | 41.5 qC | 4′′ | 70.8 CH | 4.11 (m) | |
| 15 | 27.7 CH2 | 2.31 (m) | 5′′ | 74.5 CH | 4.01 (m) |
| 16 | 23.0 CH2 | 2.02 (m); 2.12 (m) | 6′′ | 64.0 CH2 | 4.88 (dd, 11.8, 5.5) |
| 17 | 46.8 qC | 5.03 (dd, 11.8, 1.6) | |||
| 18 | 47.0 CH | 3.10 (dd, 13.4, 5.1) | Caff-1′′′ | 126.4 qC | |
| 19 | 41.1 CH2 | 2.15 (m); 2.55 (t, 13.4) | 2′′′ | 115.3 CH | 7.54 (br s) |
| 20 | 147.8 qC | 3′′′ | 147.0 qC | ||
| 21 | 29.5 CH2 | 2.08 (m); 2.17 (m) | 4′′′ | 149.8 qC | |
| 22 | 37.1 CH2 | 1.75 (m); 2.03 (m) | 5′′′ | 116.1 CH | 7.17 (d, 8.2 ) |
| 23 | 28.2 CH3 | 1.20 (s) | 6′′′ | 121.6 CH | 7.09 (dd, 8.2, 1.9) |
| 24 | 16.0 CH3 | 1.01 (s) | 7′′′ | 145.4 CH | 7.91 (d, 15.8) |
| 25 | 15.1 CH3 | 0.91 (s) | 8′′′ | 114.4 CH | 6.61 (d, 15.8) |
| 26 | 17.0 CH3 | 1.09 (s) | 9′′′ | 167.1 qC |
δ in ppm; 1H-NMR: 600 MHz and 13C-NMR 150 MHz.
NMR spectroscopic data for compound 3 in pyridine-d5.
| No. | δc | δH (mult., | No. | δc | δH (mult., |
|---|---|---|---|---|---|
| Ag-1 | 38.9 CH2 | 0.92 (m); 1.45 (m) | 24 | 73.1 CH2 | 4.25 (d, 10.0); 4.36 (d, 10.0) |
| 2 | 28.3 CH2 | 1.86 (m); 1.93 (m) | 25 | 15.6 CH3 | 0.84 (s) |
| 3 | 79.3 CH | 3.50 (dd, 4.1, 11.7) | 26 | 17.0 CH3 | 0.91 (s) |
| 4 | 43.0 qC | 27 | 25.8 CH3 | 1.17 (s) | |
| 5 | 56.5 CH | 0.88 (br d, 11.7) | 28 | 180.1 qC | |
| 6 | 19.2 CH2 | 1.49 (m); 1.63 (m) | 29 | 25.5 CH3 | 1.55 (s) |
| 7 | 33.3 CH2 | 1.19 (m); 1.35 (m) | |||
| 8 | 39.5 qC | Glc-1′ | 105.6 CH | 4.93 (d, 7.7) | |
| 9 | 47.9 CH | 1.56 (m) | 2′ | 74.9 CH | 4.02 (dd, 8.3, 7.7) |
| 10 | 37.0 qC | 3′ | 78.2 CH | 4.21 (dd, 8.4, 8.3) | |
| 11 | 23.7 CH2 | 1.82 (m) | 4′ | 71.2 CH | 4.11 (dd, 9.6, 8.4) |
| 12 | 122.3 CH | 5.49 (br s) | 5′ | 75.3 CH | 4.10 (m) |
| 13 | 144.2 qC | 6′ | 64.3 CH2 | 4.95 (dd, 11.4, 4.7) | |
| 14 | 41.8 qC | 5.03 (br d, 10.1) | |||
| 15 | 28.1 CH2 | 1.11 (m); 2.12 (m) | Caff-1′′ | 126.6 qC | |
| 16 | 23.7 CH2 | 1.99 (m); 2.20 (m) | 2′′ | 115.7 CH | 7.49 (d, 1.6) |
| 17 | 46.6 qC | 3′′ | 147.5 qC | ||
| 18 | 44.2 CH | 3.32 (dd, 14.3, 3.9) | 4′′ | 150.0 qC | |
| 19 | 47.9 CH2 | 1.88 (m); 2.40 (t, 13.5) | 5′′ | 116.6 CH | 7.18 (d, 8.2) |
| 20 | 69.7 qC | 6′′ | 121.9 CH | 7.05 (dd, 8.2, 1.6) | |
| 21 | 36.0 CH2 | 1.08 (m); 2.02 (m) | 7′′ | 145.8 CH | 7.88 (d, 15.8) |
| 22 | 34.9 CH2 | 2.03 (m) | 8′′ | 114.6 CH | 6.54 (d, 15.8) |
| 23 | 23.3 CH3 | 1.51 (s, 3H) | 9′′ | 167.4 qC |
δ in ppm; 1H-NMR: 600 MHz and 13C-NMR 150 MHz.
Cytotoxicity against Cancer Cell Lines of compounds 1–5 (IC50, µM).
| Compounds | HepG2 | HCT-116 | SGC-7901 |
|---|---|---|---|
| 1 | >100 | >100 | 87.0 |
| 2 | >100 | >100 | >100 |
| 3 | >100 | >100 | >100 |
| 4 | >100 | >100 | >100 |
| 5 | 15.2 | 9.1 | 41.0 |
| Adriamycin | 0.46 | 3.3 | 5.1 |